<DOC>
	<DOCNO>NCT02955654</DOCNO>
	<brief_summary>The purpose study determine whether acceptance commitment therapy effective treatment SSRIs-resistant obsessive- compulsive disorder .</brief_summary>
	<brief_title>Acceptance Commitment Therapy SSRI-Resistant Obsessive Compulsive Disorder</brief_title>
	<detailed_description>The patient SSRI-resistant randomized ACT , aripiprazole , SMT . Independent evaluator , blind treatment , evaluate patient study.The Yale-Brown Obsessive Compulsive Scale ( YBOCS ) use measure OCD severity .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1. age 18 65 ; 2. less 9 year education ; 3. DSMIV diagnosis OCD 4. moderately symptomatic ( YaleBrown Obsessive Compulsive Scale score≥16 ) 5. receive least two kind SSRIs optimal dose 12 week An optimal dose describe follow : clomipramine hydrochloride , least 225 mg/d ; fluoxetine , least 60 mg/d ; paroxetine hydrochloride , least 60 mg/d ; sertraline hydrochloride , least 200 mg/d ; fluvoxamine , least 250 mg/d ; citalopram hydrobromide , least 60 mg/d ; escitalopram oxalate , least 40 mg/d.Patients unable tolerate suppose optimal dos also eligible maximally tolerate dose . 1. comorbid Axis I psychiatric disorder 2. drug abuse last 3 month 3 . HAMD &gt; 25 4. severe receive ACT evaluation 5. high risk suicide 6. pregnant prepare pregnancy 7. somatic disorder 8. receive aripiprazole ( ≥10mg 8weeks ) ACT ( 8 time within 2 month ) 9. treat one kind SSRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>